Electromedical Technologies, Inc. (EMED)
OTC Markets OTCID
Price as at 30 Sept 2026, 17:46 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Electromedical Technologies, Inc. trades at $0.00. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Electromedical Technologies, Inc.
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its EMED data?
Fundamentals for EMED come from company filings and exchange data, as listed on OTC Markets OTCID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:46 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for EMED, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.